In recent years, people around the world have experienced difficulty obtaining the medications they need to manage their acute and chronic health concerns. Adderall, amoxicillin, and Tamiflu have recently made news for being in short supply, but they're just the latest in a long line of drugs whose availability has been disrupted. Many other drugs have suffered shortages over the years, as we in the anesthesiology community know all too well. Uncertainty over drug availability inevitably leads to questions. How big is the drug shortage problem? Is the problem getting worse or is recency bias simply making it feel that way? What is being done to combat it, and what can anesthesiologists and other physicians do locally and globally to alleviate supply challenges? In our role as clinical pharmacologists and patient safety advocates, anesthesiologists must understand the current problem and the answers to these questions.

The American Society of Health-System...

You do not currently have access to this content.